Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: Effectiveness and side-effects

Anticancer Research

Volumn 27, Issue 3 B, 2007, Pages 1653-1656

  Stathopoulos, G P ^a,b   Koutantos, J ^a   Lazaki, H ^a   Rigatos, S K ^a   Stathopoulos, J ^a   Deliconstantinos, G ^a  

^a Errikos Dunant Hospital   (Greece)

^b NONE   (Greece)

Author keywords

Breast cancer; Capecitabine; Colorectal cancer

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CAPECITABINE; CHOLESTEROL; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; TAXANE DERIVATIVE; TRIACYLGLYCEROL;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BONE MARROW TOXICITY; BREAST CANCER; CARDIOTOXICITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HAND FOOT SYNDROME; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PANCREAS ISLET CELL TUMOR; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34249290797     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Miwa M, Ura M, Nishida M et al: Design of a novel fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil relatively in tumors by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34: 1274-1281, 1998.
2. Diasio RB: An evolving role for oral fluoropyrimidine drugs. J Clin Oncol 20: 894-896, 2002.
3. Blum JL, Jones SE, Buzdar AU et al: Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 17: 485-493, 1999.
4. Van Cutsem E, Twelves C, Cassidy J et al: Oral capecitabine compared with intravenous 5-fluorouracil plus leucovorin (Mayo Clinic regimen) in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19: 4097-4105, 2001.
5. O'Shaughnessy J, Miles D, VuKelja S et al: Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 20: 2812-2823, 2002.
6. Hoff PM, Ansari R, Batist G et al: Comparison of oral capecitabine (Xeloda) vs. intravenous 5-fluorouracil plus leucovorin (Mayo Clinic regimen) as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19: 2282-2292, 2001.
7. Mackean M, Plating A, Twelves C et al: Phase I pharmacologic study in intermittent twice-daily therapy with capecitabine in patients with advanced and/or metastatic cancer. J Clin Oncol 20: 160-164, 2002.
8. Cartwright TH, Cohn A, Varkey JA et al: A phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer. J Clin Oncol 20: 160-164, 2002.
9. Therasse P, Arbuck SG, Eisenhower EA et al: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92: 205-216, 2000.
10. Hess V, Salzberg M, Borner M et al: Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: A phase I/II trial. J Clin Oncol 21: 66-68, 2003.
11. Herrmann R, Bormer M, Morant R et al: Combining gemcitabine (GEM) and capecitabine (CAP) in advanced pancreatic cancer. Results of a phase I trial. Proc Am Soc Clin Oncol 19: 267a, 2000 (Abstract 1038).
12. Ardavanis AS, Ioannidis GN, Orphanos GS and Rigatos GA: Salvage treatment with single agent capecitabine in patients with heavily pretreated advanced colorectal cancer. Anticancer Res 26: 1669-1672, 2006.
13. Pasetto LM and Monfardini S: The role of capecitabine in the treatment of colorectal cancer in the elderly. Anticancer Res 26: 2381-2386, 2006
14. Ohnishi H, Ito C, Suxuki K et al: Effects of 5-methyl-7 diethylamide-s-triazolo(1,5-a)pyrimidine (trapidil) on various experimental hyperlipemias. Article in Japanese. Nippon Yakurigaku Zasshi 76: 469-475, 1980.
15. Stathopoulos GP, Stergiou GP, Perrea-Kostarelis DN et al: Influence of 5-fluorouracil on serum lipids. Acta Oncologica 34(2): 253-256, 1995.